Effects of myeloid cell growth factors on alkaline phosphatase, myeloperoxidase, defensin and granulocyte colony-stimulating factor receptor mRNA expression in haemopoietic cells of normal individuals and myeloid disorders

British Journal of Haematology

Volumn 92, Issue 1, 1996, Pages 9-22

  Tsuruta, Toshihisa ^a,c   Tani, Kenzaburo ^a   Shimane, Miyuki ^a   Ozawa, Keiya ^a   Takahashi, Satoshi ^a   Tsuchimoto, Daisuke ^a   Takahashi, Keisuke ^a   Nagata, Shigekazu ^b   Sato, Noriharu ^a   Asano, Shigetaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Osaka National Science Institute   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Alkaline phosphatase; CSF; Defensin; IL 3; Myeloperoxidase

Indexed keywords

ALKALINE PHOSPHATASE; DEFENSIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MESSENGER RNA; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ADULT; AGED; ALKALINE PHOSPHATASE; BLOOD PROTEINS; BLOTTING, NORTHERN; CELL CULTURE TECHNIQUES; COLONY-STIMULATING FACTORS; DEFENSINS; FEMALE; GENE EXPRESSION; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-3; LEUKEMIA, MYELOID; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PEROXIDASE; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RNA, MESSENGER;

EID: 0030040434     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.299833.x     Document Type: Article

References (39)

1. Antin, J.H., Smith, B.R., Holmes, W. & Rosenthal, D.S. (1988) Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood, 72, 705-713.
2. Atkin, C.L., Andersen, M.R. & Eyre, H.J. (1982) Abnormal neutrophil myeloperoxidase from a patient with chronic myelocytic leukemia. Archives of Biochemistry and Biophysics, 214, 284-292.
3. Bendix-Hansen, K.B. & Kerndrup, G. (1985) Myeloperoxidase-deficient polymorphonuclear leucocytes. V. Relation to FAB-classification and neutrophil alkaline phosphatase activity in primary myelodysplastic syndromes. Scandinavian Journal of Haematology, 35, 197-200.
4. Bendix-Hansen, K.B., Kerndrup, G. & Pedersen, B. (1986) Myeloperoxidase deficient polymorphonuclear leucocyte. VI. Relation to cytogenetic abnormalities in primary myelodysplastic syndromes. Scandinavian Journal of Haematology, 36, 3-7.
5. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
6. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Annals of Internal Medicine, 103, 620-625.
7. Bettelheim, P., Valent, P., Andreeff, M., Tafuri, A., Haimi, J., Gorischek, C., Muhm, M., Sillaber, C., Haas, O., Vieder, L., Mauer, D., Schulz, G., Speiser, W., Geissler, K., Kier, P., Hinterberger, W. & Lechner, K. (1991) Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood, 77, 700-711.
8. Bonilla, M.A., Gillio, A.P., Ruggeiro, M., Kernan, N.A., Brochstein, J.A., Abboud, M., Fumagalli, L., Vincent, M., Gabrilove, J.L., Welte, K., Souza, L.M. & O'Reilly, R.J. (1989) Effect of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. New England Journal of Medicine, 320, 1574-1580.
9. Boogaerts, M.A., Nelissen, V., Roelant, C. & Goossens, W. (1983) Blood neutrophil function in primary myelodysplastic syndromes. British Journal of Haematology, 55, 217-227.
10. Boxer, L.A. & Smolen, J.E. (1988) Neutrophil granule constituents and their release in health and disease. Hematology/Oncology Clinics of North America, 2, 101-134.
11. Cech, P., Schneider, P. & Bachmann, F. (1982) Partial myeloperoxidase deficiency. Acta Haematologica, 67, 180-184.
12. Clark, S.C. & Kamen, R. (1987) The human hematopoietic colony-stimulating factors. Science, 236, 1229-1237.
13. Daher, K.A., Lehrer, R.I., Ganz, T. & Kronenberg, M. (1988) Isolation and characterization of human defensin cDNA clones. Proceedings of the National Academy of Sciences of the United States of America, 85, 7327-7331.
14. Fukunaga, R., Seto, Y., Mizushima, S. & Nagata, S. (1990) Three different mRNAs encoding human granulucyte colony-stimulating factor receptor. Proceedings of the National Academy of Sciences of the United States of America, 87, 8702-8706.
15. Ganser, A., Lindemann, A., Ottmann, O.G., Seipelt, G., Geissler, G., Kanz, L., Frisch, J., Schulz, G., Herrmann, F., Mertelsmann, R. & Hoelzer, D. (1992) Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: result of a phase I study. Blood, 79, 2583-2591.
16. Ganser, A., Seipelt, G., Lindemann, A., Ottmann, O.G., Falk, S., Eder, M., Herrmann, F., Becher, R., Höffken, K., Büchner, T., Klausmann, M., Frisch, J., Schulz, G., Mertelsmann, R. & Hoelzer, D. (1990) Effects of recombinant human interleukin-3 in patients with myelodysplastic syndrome. Blood, 76, 455-462.
17. Gunning, P., Ponte, P., Okayama, H., Engel, J., Blau, H. & Kedes, L. (1983) Isolation and characterization of full-length cDNA clones for human α-, β, and γ-actin mRNAs: skeletal but not cytoplasmic actins have an aminoterminal cysteine that is subsequently removed. Molecular and Cellular Biology, 3, 787-795.
18. Hammond, W.P., IV, Price, T.H., Souza, L.M. & Dale, D.C. (1989) Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. New England Journal of Medicine, 320, 1306-1311.
19. Hayhoe, F.G.J. & Quaglino, D. (1958) Cytochemical demonstration and measurement of leucocyte alkaline phosphatase activity in normal and pathological states by a modified azo-dye coupling technique. British Journal of Haematology, 4, 375-389.
20. Kishimoto, T., Taga, T. & Akira, S. (1994) Cytokine signal transduction. Cell, 76, 253-262.
21. Kitamura, T., Takaku, F. & Miyajima, A. (1991) IL-1 up-regulates the expression of cytokine receptors on a factor-dependent human hemopoietic cell line, TF-1. International Immunology, 3, 571-577.
22. Kaplow, L.S. (1955) A histochemical procedure for localizing and evaluating leukocyte alkaline phosphatase activity in smears of blood and marrow. Blood, 10, 1023-1030.
23. Kobayashi, Y., Okabe, T., Ozawa, K., Chiba, S., Hino, M., Miyazono, K., Urabe, A. & Takaku, F. (1989) Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report. American Journal of Medicine, 86, 178-182.
24. Lee, G.R., Bithell, T.C., Foerster, J., Athens, J.W. & Lukens, J.N. (1993) Wintrobe's Clinical Hematology, 9th edn. Lea & Febiger, Philadelphia.
25. Metcalf, D. (1989) The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature, 339, 27-30.
26. Morishita, K., Kubota, N., Asano, S., Kaziro, Y. & Nagata, S. (1987) Molecular cloning and characterization of cDHA for human myeloperoxidase. Journal of Biological Chemistry, 262, 3844-3851.
27. Nand, S., Sosman, J., Godwin, J.E. & Fisher, R.I. (1994) A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes. Blood, 83, 357-360.
28. Nicholson, S.E., Oates, A.C., Harpur, A.G., Ziemiecki, A., Wilks, A.F. & Layton, J.E. (1994) Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proceedings of the National Academy of Sciences of the United States of America, 91, 2985-2988.
29. Rambaldi, A., Terao, M., Bettoni, S., Bassan, R., Battista, R., Barbui, T. & Garattini, E. (1989) Differences in expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes. Blood, 73, 1113-1115.
30. Rosenblum, D. & Petzold, S.J. (1975) Neutrophil alkaline phosphatase: comparison of enzymes from normal subjects and patients with polycythemia vera and chronic myelogenous leukemia. Blood, 45, 335-343.
31. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual, 2nd edn, pp. 7.19-7.22. Cold Spring Harbor Laboratory Press, New York.
32. Sato, N., Mori, M., Oshimura, M., Ueyama, Y., Miwa, T., Ohsawa, N., Kosaka, K. & Asano, S. (1982) Factor(s) responsible for the increase in alkaline phosphatase activity of postmitotic granulocytes from normal individuals and patients with chronic myeloid leukemia. Blood, 59, 141-147.
33. Silvennoinen, O., Witthuhn, B.A., Quelle, F.W., Cleveland J.L., Yi, T. & Ihle, J.N. (1993) Structure of murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proceedings of the National Academy of Sciences of the United States of America, 90, 8429-8433.
34. Teshima, H., Ishikawa, J., Kitayama, H., Yamagami, T., Hiraoka, A., Nakamura, H., Shibata, H., Masaoka, T. & Takaku, F. (1989) Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study. Experimental Hematology, 17, 853-858.
35. Vadhan-Raj, S., Keating, M., LeMaistre, A., Hittelman, W.N., McCredie, K., Trujillo, J.M., Broxmeyer, H.E., Henney, C. & Gutterman, J.U. (1987) Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome. New England Journal of Medicine, 317, 1545-1552.
36. Verhoef, G. & Boogaerts, M. (1991) In vivo administration of granulocyte-macrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromes. British Journal of Haematology, 79, 177-184.
37. Wachstein, M. (1946) Alkaline phosphatase activity in normal and abnormal human blood and bone marrow cells. Journal of Laboratory and Clinical Medicine, 31, 1-17.
38. Weiss, M.J., Henthorn, P.S., Lafferty, M.A., Slaughter, C., Raducha, M. & Harris, H. (1986) Isolation and characterization of cDNA encoding a human liver/bone/kidney-type alkaline phosphatase. Proceedings of the National Academy of Sciences of the United States of America, 83, 7182-7186.
39. Weiss, M., Yokoyama, C., Shikama, Y., Naugle, C., Druker, B. & Sieff, C.A. (1993) Human granulocyte-macrophage colony-stimulating factor receptor signal transduction requires the proximal cytoplasmic domains of the α and β subunits. Blood, 82, 3298-3306.